arrow
T

Travis Stams

novartis biomedical research
H指数:26
被引数:3,622

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Author Correction: Targeting the SHOC2–RAS interaction in RAS-mutant cancers

作者更正: 靶向RAS突变癌症中的SHOC2-RAS相互作用

Nature
IF48.5
2025-07-010
OA
Targeting the SHOC2-RAS interaction in RAS-mutant cancers

靶向RAS突变癌症中的SHOC2-RAS相互作用

NATURE
IF48.5
2025-05-071
OA
Identification of TNO155, an Allosteric SHP2 Inhibitor for the Treatment of Cancer
2020-09-10131
PREAI
Allosteric SHP2 phosphatase inhibition: Multiple mechanisms and chemotypes
2019-07-010
PRE
Optimization of Fused Bicyclic Allosteric SHP2 Inhibitors (vol 62, pg 1781, 2019)
2019-03-221
OAAI
6-Amino-3-methylpyrimidinones as Potent, Selective, and Orally Efficacious SHP2 Inhibitors (vol 62, pg 1793, 2019)
2019-03-221
OAAI
Optimization of Fused Bicyclic Allosteric SHP2 Inhibitors
2019-01-2872
OAAI
6-Amino-3-methylpyrimidinones as Potent, Selective, and Orally Efficacious SHP2 Inhibitors
2019-01-2875
OAAI
Simultaneous inhibition of SHP2 phosphatase at two allosteric sites
2018-07-011
PRE
Dual Allosteric Inhibition of SHP2 Phosphatase
2018-01-05110
OAAI
Conformational activation and allosteric inhibition of SHP2 in RTK-driven cancers
2017-07-010
PRE
Antibacterial and Solubility Optimization of Thiomuracin A
2016-07-1214
PREAI
Allosteric Inhibition of SHP2: Identification of a Potent, Selective, and Orally Efficacious Phosphatase Inhibitor
2016-07-12248
OAAI
Identification of NVP-TNKS656: The Use of Structure-Efficiency Relationships To Generate a Highly Potent, Selective, and Orally Active Tankyrase Inhibitor
2013-08-13114
PRE